Medical Care / Microbiome Therapeutics Market - Global Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions And By Key Players: Seres Therapeutics, Assembly Biosciences, Synthetic Biologics
Microbiome Therapeutics Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Seres Therapeutics, Assembly Biosciences, Synthetic Biologics
Registering a CAGR of 58.6% over the forecast period of 2022-2027, the global Microbiome Therapeutics market is anticipated to reach the market value of US$ 143.6 million in the year 2027 from US$ 1.5 billion in the year 2021.
Microbiome Therapeutics Market Overview
The human microbiome has co-evolved with humans for centuries, including bacteria, viruses, fungi, Achaeans, etc. The human microbiome is now one of the fastest-growing areas of biology and is considered a newly discovered organ with the potential to have a tremendous impact on human health. Microbiome therapeutics is therapies that are designed to disrupt unhealthy microbial ecological networks and that catalyze the establishment of healthy ones.
The microbiome therapeutics market is projected to observe substantial growth over the forecast period, owing to the growing prevalence of chronic diseases such as cancer, diabetes and obesity. Microbiome therapeutics is used to treat a wide range of disorders and diseases by restoring the balance of bacteria in the body. The growing demand for immunotherapies and rising prevalence of digestive-related diseases are some of the major factors driving this market.
Industry Updates:
Mar. 18, 2022, SERES THERAPEUTICS PRESENTS PRECLINICAL RESEARCH ON INVESTIGATIONAL MICROBIOME THERAPEUTIC SER-155 AT THE 2022 EUROPEAN BONE MARROW TRANSPLANTATION ANNUAL MEETING-
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, will present preclinical findings tomorrow at the European Bone Marrow Transplantation (EBMT) Annual Meeting that suggest SER-155 works by targeting the host immune response, potentially allowing patients undergoing hematopoietic stem cell transplantation (HSCT) to avoid infection or Graft-versus-Host Disease (GvHD), which currently afflict about half of this patient population. SER-155 is being evaluated in an ongoing Phase 1b clinical trial.
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced today that it has entered into an agreement with Nestlé Health Science to jointly commercialize SER-109, Seres’ investigational oral microbiome therapeutic for recurrent Clostridioides difficile infection(CDI), in the United States (U.S.) and Canada. If approved, SER-109 would become the first-ever FDA-approved microbiome therapeutic.
What are the major Applications, Types and Regions for Microbiome Therapeutics Market?
Microbiome TherapeuticsMarket is segmented based on the type, applications, companies and regions.
Market Volume (%) By Type, it is segmented into
Upper GIT
Lower GIT
Others
Market Volume (%) By Applications it is segmented into
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-Oncology
Other
Microbiome Therapeutics Market Regional Analysis
The U.S. is expected to contribute the highest market share of over 44.7% by 2027 in the global microbiome therapeutics market. The early launch of new drugs in the U.S. and rapid penetration are expected to drive the growth of the U.S. microbiome therapeutics market.
All these factors greatly affect the Microbiome Therapeutics market growth. It further aims at providing complete overview on detailed assessment of significant features of different industries including sales value, sales volume, market revenue, and demand size, sales growth, pricing analysis and changing market growth factors in regions such as Follows,
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
The Microbiome Therapeutics Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Microbiome Therapeutics Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Microbiome Therapeutics Market report scope?
The report includes in-depth assessment of the competitive landscape, product market sizing (Value and Volume), product benchmarking, market trends, product developments, financial analysis, strategic analysis and many more to measure the impact forces and potential opportunities of the market. As well as this the report also includes a study of major developments in the market like product launches, agreements, acquisitions, collaborations, mergers and many more to comprehend the prevailing market dynamics at current and its impact in the forecast period 2012-2027.
Report Attributes
Report Details
Forecast Period 2022 to 2027 CAGR (Value and Volume)
CAGR of 58.6% during the review period (2022 to 2027).
Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022)
Upper GIT
Lower GIT
Others
Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-Oncology
Others
Quantitative units
Revenue in USD million/billion and CAGR from 2022 to 2027
Yes, the report can be customized as per your needs
Key Highlights from this Microbiome Therapeutics Report
A comprehensive backdrop analysis, which contains an assessment of the parent market
Essential changes in market dynamics.
Market segmentation up to the second or third level.
Historical, current, and projected size of the market from the standpoint of both value and volume.
Reporting and evaluation of recent industry developments.
Market shares and strategies of major players.
Emerging niche segments and regional markets.
An objective assessment of the trajectory of the market.
Recommendations to companies for strengthening their foothold in the market.
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
Frequently Asked Questions
What is the study period of this market?
The Microbiome Therapeutics Market is studied from 2017 - 2027.
What is the growth rate of Microbiome Therapeutics Market?
The Microbiome Therapeutics Market is growing at a CAGR of 58.6% over the next 5 years.
Who are the key players in Microbiome Therapeutics Market?
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
